Mirati Therapeutics
MRTX
#3009
Rank
C$5.91 B
Marketcap
$84.30
Share price
0.00%
Change (1 day)
59.85%
Change (1 year)

Mirati Therapeutics (MRTX) - Cash on Hand

Cash on Hand as of September 2023 : C$1.40 Billion

According to Mirati Therapeutics's latest financial reports the company has C$1.40 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Mirati Therapeutics - Cash on Hand chart (from 2005 to 2023)

Cash on Hand by year

Year Cash on Hand Change
2022-12-31C$1.47 B-22.62%
2021-12-31C$1.90 B7.23%
2020-12-31C$1.77 B226.98%
2019-12-31C$0.54 B78.62%
2018-12-31C$0.30 B60.03%
2017-12-31C$0.18 B148.73%
2016-12-31C$76.24 M-55.07%
2015-12-31C$0.16 B399.01%
2014-12-31C$34 M-48.53%
2013-12-31C$66.07 M79.67%
2012-12-31C$36.77 M27.6%
2011-12-31C$28.82 M291.75%
2010-12-31C$7.35 M-58.07%
2009-12-31C$17.54 M-54.52%
2008-12-31C$38.57 M-36.96%
2007-12-31C$61.18 M-6.89%
2006-12-31C$65.7 M149.94%
2005-12-31C$26.28 M-36.47%
2004-12-31C$41.38 M34.25%
2003-12-31C$30.82 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
C$0.55 B-60.48%๐Ÿ‡บ๐Ÿ‡ธ USA
C$0.18 M-99.99% Bahamas